Nano-Carriers in Biofilm-Associated Infections: Clinical Challenges, Regulatory Hurdles, and Translational Perspectives.
Although considerable advancements have been made in treating biofilm infections through the use of nanocarriers, there are still several issues that need to be addressed before moving into clinical practice.